ABSTRACT
The purpose of this study is to determine the prevalence in diabetic retinopathy in type 2 diabetic (DM) patients and to establish associated factors. Methods: Hospital based descriptive study was conducted from April 2017 to March 2018 in the Department Of Ophthalmology, Govt Medical College Kannur, Pariyaram Known diabetics were evaluated for the prevalence of diabetic retinopathy (DR) and to establish relation with age, sex, duration of diabetes, type of medications, hypertension, end organ disease, HbA1c, body mass index. Results: Out of 293 patients with type 2 DM, 182 (62.1%) were males and 111(37.9%) female. Mean patient age was 56.7 ± 11.2 years, with duration of diabetic less than 10yrs 185(63.1%) and for more than or equal to 10 yrs. 108(36.9%). Majority of the patients 228 (77.8%) were on oral hypoglycemic agents, 26 (8.9%) on insulin and 39 (13.3%) on both. Conclusion: Prevalence of DR is high in our study132(45.1%) and DR is significantly associated with male gender, older age, longer duration of diabetic state, poorly controlled blood sugars (HbA1c levels) and in patients with hypertension.
ABSTRACT
The objective of the study is to assess the central corneal thickness (CCT) among type 2 diabetes mellitus patients and to correlate the central corneal thickness with duration of diabetes, HbA1c and severity of diabetic retinopathy. Methods: A hospital based descriptive study was conducted in Govt Medical College Kannur, Pariyaram, from April 2017 to March 2018.CCT of known diabetic patients was correlated with duration of diabetes, HbA1c and severity of retinopathy. Results: The mean central corneal thickness in diabetic patient was 550.1± 35.0µm with a range between 364 and 665 µm. Correlation of duration of diabetes and severity of diabetic retinopathy were not statistically significant. The CCT was thicker in patients with HbA1c more than 7% than HbA1c less than7% (p=0.005) which was statistically significant. Conclusion: We found that higher HBA1c level may be a marker for predicting the increase in CCT in patients with type II diabetes.